32.41
前日終値:
$34.69
開ける:
$32.4
24時間の取引高:
354.11K
Relative Volume:
0.41
時価総額:
$237.32M
収益:
-
当期純損益:
$-112.46M
株価収益率:
-19.77
EPS:
-1.64
ネットキャッシュフロー:
$-99.89M
1週間 パフォーマンス:
+6.58%
1か月 パフォーマンス:
-21.36%
6か月 パフォーマンス:
+91.20%
1年 パフォーマンス:
+113.16%
Vor Biopharma Inc Stock (VOR) Company Profile
VOR を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
VOR
Vor Biopharma Inc
|
32.43 | 237.32M | 0 | -112.46M | -99.89M | -1.64 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
380.00 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
449.56 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
555.68 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
711.63 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
328.11 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-06-30 | アップグレード | H.C. Wainwright | Neutral → Buy |
2022-07-26 | 開始されました | Wedbush | Outperform |
2022-04-27 | 開始されました | Goldman | Neutral |
2021-12-17 | 開始されました | H.C. Wainwright | Buy |
2021-12-03 | 開始されました | Robert W. Baird | Outperform |
2021-12-02 | 開始されました | Oppenheimer | Outperform |
2021-10-19 | 開始されました | JMP Securities | Mkt Outperform |
2021-03-25 | 開始されました | B. Riley Securities | Buy |
2021-03-03 | 開始されました | Barclays | Overweight |
2021-03-03 | 開始されました | Evercore ISI | Outperform |
2021-03-02 | 開始されました | Goldman | Sell |
2021-03-02 | 開始されました | Stifel | Buy |
すべてを表示
Vor Biopharma Inc (VOR) 最新ニュース
Vor Biopharma: Transformed Company Is A High Risk Buy On Autoimmune Disease Promise - Seeking Alpha
Vor Biopharma Shares Slide Following Warrant Registration Filing - MSN
Vor Biopharma stock drops after filing to register warrant shares By Investing.com - Investing.com Nigeria
Vor Biopharma stock drops after filing to register warrant shares - Investing.com
Vor Biopharma (VOR) Registers 51M Shares for Resale, Warrants in Focus - GuruFocus
Vor Biopharma files for offering of up to 51 million common shares by the selling stockholdersSEC filing - MarketScreener
Vor Biopharma (VOR) files for 51M share offering by selling stockholders - StreetInsider
Vor Biopharma upgraded to Buy at Stifel on telitacicept prospects - Seeking Alpha
Stifel upgrades Vor Biopharma stock to Buy on telitacicept prospects - Investing.com India
Stifel Nicolaus Upgrades Vor Biopharma (NYSE:VOR) to Buy - MarketBeat
Vor Biopharma climbs after Stifel upgrades rating on autoimmune drug potential - TradingView
Vor Biopharma (NYSE:VOR) Stock Price Down 8.6% Following Insider Selling - MarketBeat
Vor Biopharma’s Strategic Moves and Telitacicept’s Potential Drive Buy Rating Amid Stock Decline - TipRanks
Vor Bio appoints Navid Khan as chief medical affairs officer By Investing.com - Investing.com South Africa
Vor Bio appoints Navid Khan as chief medical affairs officer - Investing.com
Vor Biopharma (VOR) Sees Significant Increase in Borrow Rate - GuruFocus
Vor Bio Appoints Navid Z. Khan, Ph.D., as Chief Medical Affairs Officer - GlobeNewswire
7 Successful Drug Launches: Vor Bio Taps VYVGART Launch Veteran Navid Khan as Medical Affairs Chief - Stock Titan
Vor Biopharma (NASDAQ:VOR) Shares Down 7.2%What's Next? - MarketBeat
Vor Biopharma (NYSE:VOR) Major Shareholder Reprogrammed Interchange Llc Sells 22,363 Shares - MarketBeat
Analysts Set Vor Biopharma Inc. (NYSE:VOR) Price Target at $6.07 - MarketBeat
Street Watch: Is Vor Biopharma Inc stock overvalued or fairly pricedTrade Entry Summary & Proven Capital Preservation Tips - خودرو بانک
Vor Biopharma (NYSE:VOR) Major Shareholder Reprogrammed Interchange Llc Sells 447,278 Shares - MarketBeat
Insider Selling: Vor Biopharma (NYSE:VOR) Major Shareholder Sells 20,000 Shares of Stock - MarketBeat
Momentum Shift: What is the PEG ratio of Vor Biopharma IncQuarterly Trade Report & Entry Point Confirmation Signals - خودرو بانک
Insider Selling: Vor Biopharma (NYSE:VOR) Major Shareholder Sells 14,240 Shares of Stock - MarketBeat
Risk Report: Is Vor Biopharma Inc. part of any ETF2025 Price Action Summary & Verified Swing Trading Watchlists - khodrobank.com
Reprogrammed Interchange Llc Sells 300,000 Shares of Vor Biopharma (NYSE:VOR) Stock - MarketBeat
Vor Biopharma Inc. recovery potential after sell offInflation Watch & Weekly Stock Performance Updates - newser.com
How to interpret RSI for Vor Biopharma Inc. stockMarket Performance Summary & Verified Technical Signals - newser.com
Will Vor Biopharma Inc. rebound enough to break evenPortfolio Profit Report & Fast Moving Stock Watchlists - newser.com
Vor Biopharma ten percent owner sells $688k in shares By Investing.com - Investing.com Australia
Vor Biopharma (VOR) Faces Trading Halt Amid Reverse Stock Split and Share Sale - GuruFocus
Vor Biopharma trading halted on Thursday, news pending (VOR:NASDAQ) - Seeking Alpha
Relative strength of Vor Biopharma Inc. in sector analysis2025 Momentum Check & Real-Time Chart Pattern Alerts - newser.com
Will Vor Biopharma Inc. bounce back from current supportWeekly Investment Report & Weekly Watchlist for Hot Stocks - newser.com
What momentum shifts mean for Vor Biopharma Inc.Market Activity Report & Reliable Entry Point Trade Alerts - newser.com
What’s the recovery path for long term holders of Vor Biopharma Inc.July 2025 Pullbacks & Low Risk High Reward Ideas - newser.com
Vor Biopharma ten percent owner sells $688k in shares - Investing.com
Using Bollinger Bands to evaluate Vor Biopharma Inc.Portfolio Gains Summary & Community Consensus Picks - newser.com
Gains Report: Is Vor Biopharma Inc stock overvalued or fairly pricedWeekly Trend Report & AI Driven Price Predictions - khodrobank.com
Vor Biopharma Announces 1-for-20 Reverse Stock Split - TipRanks
Vor Biopharma (NASDAQ:VOR) Rating Increased to Hold at Zacks Research - MarketBeat
Vor Bio Announces Oral Presentation of 48-Week China Phase - GlobeNewswire
Vor Biopharma announces 1-for-20 reverse stock split effective Thursday - Investing.com India
Weekly Recap: How cyclical is Vor Biopharma Inc.’s revenue stream2025 Market Outlook & High Win Rate Trade Tips - khodrobank.com
CEO Moves: Can Vor Biopharma Inc keep up with sector leadersJuly 2025 Highlights & Daily Market Momentum Tracking - خودرو بانک
Vor Biopharma Inc (VOR) 財務データ
収益
当期純利益
現金流量
EPS
Vor Biopharma Inc (VOR) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Reprogrammed Interchange LLC | 10% Owner |
Sep 15 '25 |
Sale |
1.64 |
400,000 |
656,320 |
33,228,487 |
Reprogrammed Interchange LLC | 10% Owner |
Sep 12 '25 |
Sale |
1.75 |
300,000 |
526,230 |
33,628,487 |
Reprogrammed Interchange LLC | 10% Owner |
Sep 11 '25 |
Sale |
1.83 |
284,805 |
521,421 |
33,928,487 |
Reprogrammed Interchange LLC | 10% Owner |
Sep 08 '25 |
Sale |
1.99 |
464,421 |
924,058 |
35,012,518 |
Reprogrammed Interchange LLC | 10% Owner |
Sep 09 '25 |
Sale |
2.00 |
449,226 |
898,632 |
34,563,292 |
Reprogrammed Interchange LLC | 10% Owner |
Sep 10 '25 |
Sale |
1.82 |
350,000 |
635,285 |
34,213,292 |
Reprogrammed Interchange LLC | 10% Owner |
Sep 03 '25 |
Sale |
2.00 |
554,612 |
1,107,061 |
36,329,955 |
Reprogrammed Interchange LLC | 10% Owner |
Sep 04 '25 |
Sale |
1.93 |
453,016 |
873,641 |
35,876,939 |
Reprogrammed Interchange LLC | 10% Owner |
Sep 05 '25 |
Sale |
1.97 |
400,000 |
787,280 |
35,476,939 |
大文字化:
|
ボリューム (24 時間):